Avigen Ltd

Startup

Avigen is a preclinical Contract Research Organisation (CRO) specialising in the discovery and validation of cell-based immunotherapies and biologics through cellular avidity profiling, the functional binding strength between immune and target cells. Our proprietary platform enables high-throughput, target-specific testing, sorting, and isolation of effector cells, providing physiologically relevant data that better predicts in-vivo performance. We collaborate with biotech and pharmaceutical teams across modalities such as CAR-T, TCR-T, NK, CAR-NK and cell engagers to streamline development, reduce translational risk, and enable confident, data-driven therapeutic translation.